Personalized diet plan for lupus based on genetics
Part of Immune system & allergy, Skin clinical trials.
This study looks at how your genes can help create a personalized diet plan to manage lupus symptoms. The goal is to see if a diet based on your genetic makeup can help you live a healthier lifestyle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lupus, confirmed using a standard medical checklist (2019 EULAR/ACR criteria).
- You are at least 18 years old.
- You are not currently pregnant or breastfeeding.
- You are not already following a special diet for autoimmune diseases.
- You do not have serious health conditions like active cancer, severe kidney failure, or acute heart failure.
- You are not taking more than 20 mg of prednisone (or an equivalent steroid) per day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study is trying to better understand lupus (SLE) by looking at different types of the disease. It may help doctors find more personalized treatments in the future.
This study tests whether a specific lupus “low disease activity” target (called LLDAS) works the same way in people across the Asia-Pacific region. It may help doctors use clearer goals to track how well lupus is controlled.
This study tests whether a special type of stem cell treatment (called UC-MSC) can help calm lupus when standard medicines aren't enough. It's for people with active lupus who have tried other non-steroid medications.
This study looks at a “treat-to-target” approach for people with systemic lupus erythematosus (SLE) to help control symptoms to a specific goal. It may help guide medication changes when lupus is not fully calm yet.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.